The International Contraceptive Access (ICA) Foundation was established in December 2003 and is a collaboration between the Bayer, a world-wide leading specialty pharmaceutical company, and Population Council, an international nonprofit nongovernmental organization. 

The objective of the Foundation is to provide local service-delivery organizations with the levonorgestrel releasing intrauterine system (LNG IUS) contraceptive devices on a not-for-profit basis and ultimately serve the reproductive needs of women in resource-poor settings, primarily in developing countries. 

By March 2019, the ICA Foundation has donated 136.615 LNG IUS to organizations in 36 countries. Country projects include collaborations with local not-for-profit organizations, hospitals, and global partners with a network of service delivery facilities in developing countries. Donation recipients work through a variety of means to provide women access to contraceptive options and quality family planning services. 

As the Foundation's focus is service delivery, product donations for research purposes are not accepted.